title: Should psychologists be granted prescription privileges? A review of the prescription privilege debate for psychiatrists.
abstract: BACKGROUND
  The debate over whether clinical psychologists should be granted the right to prescribe psychoactive medication has received considerable attention over the last 2 decades in the US, but there has been relatively little discussion of this controversial topic among Canadian mental health professionals, namely psychologists and psychiatrists. Proponents of prescription privileges (PPs), including the American Psychological Association (APA), argue that psychologists do not and cannot function as independent professionals because the medical profession places many restrictions on their practice. It is believed that PPs would help circumvent professional psychology's impending marginalization by increasing psychology's scope of practice. Proponents also argue that PPs would enhance mental health services by increasing public access to professionals who can prescribe.
  
  
  OBJECTIVE
  The purpose of this article is to inform psychiatrists about the major arguments presented for and against PPs for psychologists and to discuss the major implications of PPs for both professional psychology and psychiatry.
  
  
  METHODS
  We conducted a literature search of relevant articles published from 1980 to the present appearing on Psychlit and Medline databases, using "prescription privileges" and "psychologists" as search titles.
  
  
  CONCLUSIONS
  Although proponents present several compelling arguments in favour of PPs for psychologists, pilot projects relating to feasibility and efficacy are either sparse or incomplete. Thus, it is too soon to tell whether PPs could or should be pursued. Clearly, more research is needed before we conclude that PPs for psychologists are a safe and necessary solution to psychology's alleged impending marginalization.
authors.affiliation: Montreal Heart Institute, Sacre-Coeur Hospital, Research Center, Montreal, QC. kiml_lavoie@yahoo.ca
authors.forename: Kim L
authors.initials: KL
authors.lastname: Lavoie
authors.forename: Richard P
authors.initials: RP
authors.lastname: Fleet
mesh_terms: D002170:Canada; D011307:Drug Prescriptions; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011586:Psychology, Clinical / Q000331:legislation & jurisprudence*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014481:United States
chemical_list: D011619:Psychotropic Drugs